This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Institut De Recherche Pour Le Developpement, Johns Hopkins University, Universidad Peruma Cayetano Heredia. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 15 
1 out of 3,806 
1 out of 1 
Years Active: 2015
Title: Michel Henri Auguste Sauvain: Innovator in Pharmaceutical Compounds
Introduction
Michel Henri Auguste Sauvain is a notable inventor based in Ramonville Saint Agne, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that have potential therapeutic uses.
Latest Patents
Sauvain holds a patent related to compounds associated with chalcones and benzothienopyrimidines. This patent outlines their synthesis and applications in treating diseases, including cancer and infections. The embodiments of this invention provide various compounds, such as Formula (I) and Formula (II) compounds, along with methods for their preparation and use.
Career Highlights
Throughout his career, Sauvain has been affiliated with reputable institutions, including the University of Louisville Research Foundation, Inc. and Universidad Peruana Cayetano Heredia. His work has focused on innovative approaches to drug development and synthesis.
Collaborations
Sauvain has collaborated with esteemed colleagues, including Gerald B. Hammond and Jose C. Aponte, contributing to advancements in his field.
Conclusion
Michel Henri Auguste Sauvain's work in pharmaceutical compounds showcases his dedication to innovation and the potential impact of his inventions on medical treatments. His contributions continue to influence the landscape of drug development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile